BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36826447)

  • 1. Triad pyrazole-thiazole-coumarin heterocyclic core effectively inhibit HSP and drive cancer cells to apoptosis.
    Gümüş M; Koca İ; Sert Y; Dişli A; Yenilmez Tunoğlu EN; Tutar L; Tutar Y
    J Biomol Struct Dyn; 2023; 41(23):14382-14397. PubMed ID: 36826447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
    Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
    Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug-resistance in hepatocellular carcinoma.
    Zhang X; He B; Chen E; Lu J; Wang J; Cao H; Li L
    J Cell Physiol; 2021 Jan; 236(1):178-192. PubMed ID: 32510618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition and apoptosis induced by osthole, a natural coumarin, in hepatocellular carcinoma.
    Zhang L; Jiang G; Yao F; He Y; Liang G; Zhang Y; Hu B; Wu Y; Li Y; Liu H
    PLoS One; 2012; 7(5):e37865. PubMed ID: 22662241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
    Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
    Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 5-aryl-3-thiophen-2-yl-1H-pyrazoles as a new class of Hsp90 inhibitors in hepatocellular carcinoma.
    Mohamady S; Ismail MI; Mogheith SM; Attia YM; Taylor SD
    Bioorg Chem; 2020 Jan; 94():103433. PubMed ID: 31785857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
    Singh AR; Joshi S; Burgoyne AM; Sicklick JK; Ikeda S; Kono Y; Garlich JR; Morales GA; Durden DL
    Mol Cancer Ther; 2016 Nov; 15(11):2553-2562. PubMed ID: 27496136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
    Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
    Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
    Harras MF; Sabour R
    Bioorg Chem; 2018 Aug; 78():149-157. PubMed ID: 29567429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Novel Indolylacrylamide Derivatives: Synthesis and Biological Evaluation.
    Hawash M; Kahraman DC; Cetin-Atalay R; Baytas SN
    Chem Biodivers; 2021 May; 18(5):e2001037. PubMed ID: 33713038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents.
    Goud NS; Ghouse MS; Vishnu J; Pranay J; Alvala R; Talla V; Qureshi IA; Alvala M
    Anticancer Agents Med Chem; 2019; 19(4):557-566. PubMed ID: 30734685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells.
    Zhang Z; Miao L; Lv C; Sun H; Wei S; Wang B; Huang C; Jiao B
    Cell Death Dis; 2013 Jun; 4(6):e657. PubMed ID: 23744357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics.
    Hawash MM; Kahraman DC; Eren F; Cetin Atalay R; Baytas SN
    Eur J Med Chem; 2017 Mar; 129():12-26. PubMed ID: 28219046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
    Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22871. PubMed ID: 34338398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells.
    Grabinski N; Ewald F; Hofmann BT; Staufer K; Schumacher U; Nashan B; Jücker M
    Mol Cancer; 2012 Nov; 11():85. PubMed ID: 23167739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxypyridinone-Coumarin Inhibits the Proliferation of MHCC97 and HepG2 Human Hepatocellular Carcinoma Cells and Down-Regulates the Phosphoinositide-3 Kinase Pathway.
    Cui X; Qin X
    Med Sci Monit; 2020 Mar; 26():e920785. PubMed ID: 32218414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
    Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
    Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclovirobuxine D Exerts Anticancer Effects by Suppressing the
    Zhang J; Chen Y; Lin J; Jia R; An T; Dong T; Zhang Y; Yang X
    DNA Cell Biol; 2020 Mar; 39(3):355-367. PubMed ID: 31913706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.
    Yang L; Hu Y; Zhou G; Chen Q; Song Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling.
    Atmaca H; Özkan AN; Zora M
    Chem Biol Interact; 2017 Feb; 263():28-35. PubMed ID: 27989600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.